{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:01:48Z","timestamp":1790438508582,"version":"4.1.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Early T-cell precursor phenotype acute lymphoblastic leukemia (ETP-ALL) is a subtype of T-ALL with a unique immunophenotype and genetic abnormalities distinct from conventional T-ALL. A subset of T lymphoblastic lymphoma (T-LLy) also demonstrates the early T-cell precursor immunophenotype and may be a counterpart of ETP-ALL. Unlike ETP-ALL, the incidence, clinical features, and genomic features of ETP-LLy are unknown. We reviewed the immunophenotyping data of 218 T-LLy patients who enrolled in the Children\u2019s Oncology Group AALL0434 clinical trial and identified 9 cases (4%) exhibiting a definitive ETP immunophenotype. We performed single-nucleotide polymorphism array profiling on 9 ETP-LLy and 15 non-ETP T-LLy cases. Compared with non-ETP T-LLy, ETP-LLy showed less frequent deletion of 9p (CKDN2A\/B), more frequent deletion of 12p (ETV6) and 1p (RPL22), and more frequent absence of biallelic T-cell receptor \u03b3 deletions. Recurrent abnormalities previously described in ETP-ALL such as deletions of 5q and 13q and gain of 6q were not observed in ETP-LLy cases. There were no failures of therapy among the ETP-LLy subtype with a 4-year event-free survival of 100%. Overall, ETP-LLy does not exhibit unifying genetic alterations but shows some distinct genomic features from non-ETP T-LLy suggesting that ETP-LLy may be a distinct entity from non-ETP T-LLy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004334","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:34:25Z","timestamp":1627054465000},"page":"2890-2900","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma"],"prefix":"10.1182","volume":"5","author":[{"given":"Xinjie","family":"Xu","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian N.","family":"Paxton","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly P.","family":"Dunsmore","sequence":"additional","affiliation":[{"name":"Health Sciences Center, University of Virginia, Charlottesville, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart S.","family":"Winter","sequence":"additional","affiliation":[{"name":"Cancer and Blood Disorders Program, Children\u2019s Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5492-3957","authenticated-orcid":false,"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and The Center for Childhood Cancer Research, The Children\u2019s Hospital of Philadelphia and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-3870","authenticated-orcid":false,"given":"Naomi J.","family":"Winick","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology, University of Texas Southwestern\/Simmons Cancer Center, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-4700","authenticated-orcid":false,"given":"Mignon L.","family":"Loh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UCSF Benioff Children\u2019s Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-3478","authenticated-orcid":false,"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Center for Cancer and Blood Disorders, Children\u2019s Hospital Colorado and the Anschutz Medical School at the University of Colorado, Aurora, CO; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[{"name":"Children\u2019s National Health System and The George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney R.","family":"Miles","sequence":"additional","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT;"},{"name":"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"2021072315342270700_B1","volume-title":"Non-Hodgkin lymphoma in children: Cancer medicine.","author":"Cairo","year":"2006"},{"key":"2021072315342270700_B2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017","edition":"revised 4th ed"},{"issue":"16","key":"2021072315342270700_B3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical impact of NOTCH1 and\/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J Clin Oncol."},{"issue":"12","key":"2021072315342270700_B4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/gcc.20924","article-title":"T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses","volume":"50","author":"Basso","year":"2011","journal-title":"Genes Chromosomes Cancer."},{"issue":"2","key":"2021072315342270700_B5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pbc.20550","article-title":"Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma","volume":"47","author":"Raetz","year":"2006","journal-title":"Pediatr Blood Cancer."},{"issue":"2","key":"2021072315342270700_B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"issue":"2","key":"2021072315342270700_B7","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2352-3026(15)00254-9","article-title":"Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis","volume":"3","author":"Conter","year":"2016","journal-title":"Lancet Haematol."},{"issue":"3","key":"2021072315342270700_B8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br J Haematol."},{"issue":"1","key":"2021072315342270700_B9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica."},{"issue":"6","key":"2021072315342270700_B10","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.3324\/haematol.2019.225078","article-title":"Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia","volume":"105","author":"Genesca","year":"2020","journal-title":"Haematologica."},{"issue":"10","key":"2021072315342270700_B11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica."},{"issue":"1","key":"2021072315342270700_B12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13045-018-0639-8","article-title":"Frequency and clinical impact of CDKN2A\/ARF\/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia","volume":"11","author":"Genesc\u00e0","year":"2018","journal-title":"J Hematol Oncol."},{"issue":"6","key":"2021072315342270700_B13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/pbc.24021","article-title":"Absence of biallelic TCR\u03b3 deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia","volume":"58","author":"Yang","year":"2012","journal-title":"Pediatr Blood Cancer."},{"issue":"7380","key":"2021072315342270700_B14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature."},{"issue":"8","key":"2021072315342270700_B15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet."},{"issue":"4","key":"2021072315342270700_B16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children\u2019s Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol."},{"issue":"22","key":"2021072315342270700_B17","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1200\/JCO.2011.40.8724","article-title":"Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"30","author":"Dunsmore","year":"2012","journal-title":"J Clin Oncol."},{"issue":"7","key":"2021072315342270700_B18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/pbc.25470","article-title":"Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children\u2019s Oncology Group Study AALL0434","volume":"62","author":"Winter","year":"2015","journal-title":"Pediatr Blood Cancer."},{"issue":"26","key":"2021072315342270700_B19","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.20.00531","article-title":"Successful outcomes of newly diagnosed T lymphoblastic lymphoma: results from Children\u2019s Oncology Group AALL0434","volume":"38","author":"Hayashi","year":"2020","journal-title":"J Clin Oncol."},{"issue":"28","key":"2021072315342270700_B20","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.20.00256","article-title":"Children\u2019s Oncology Group AALL0434: A phase III randomized clinical trial testing nelarabine in newly diagnosed T-Cell acute lymphoblastic leukemia","volume":"38","author":"Dunsmore","year":"2020","journal-title":"J Clin Oncol."},{"issue":"29","key":"2021072315342270700_B21","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.2018.77.7250","article-title":"Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children\u2019s Oncology Group AALL0434 methotrexate randomization [published correction appears in J Clin Oncol. 2019;37(9):761]","volume":"36","author":"Winter","year":"2018","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021072315342270700_B22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","article-title":"Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression","volume":"155","author":"Schiffman","year":"2011","journal-title":"Br J Haematol."},{"issue":"7-8","key":"2021072315342270700_B23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cancergen.2012.06.005","article-title":"Molecular inversion probes: a novel microarray technology and its application in cancer research","volume":"205","author":"Wang","year":"2012","journal-title":"Cancer Genet."},{"issue":"1","key":"2021072315342270700_B24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"2021072315342270700_B25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia."},{"issue":"13","key":"2021072315342270700_B26","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med."},{"issue":"17","key":"2021072315342270700_B27","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2020005381","article-title":"Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance","volume":"137","author":"Khanam","year":"2021","journal-title":"Blood."},{"issue":"16","key":"2021072315342270700_B28","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1182\/blood-2009-10-178129","article-title":"Ribosomopathies: human disorders of ribosome dysfunction","volume":"115","author":"Narla","year":"2010","journal-title":"Blood."},{"issue":"2","key":"2021072315342270700_B29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia","volume":"45","author":"De Keersmaecker","year":"2013","journal-title":"Nat Genet."},{"issue":"6","key":"2021072315342270700_B30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.immuni.2007.04.012","article-title":"Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint","volume":"26","author":"Anderson","year":"2007","journal-title":"Immunity."},{"issue":"18","key":"2021072315342270700_B31","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1182\/blood-2012-03-415349","article-title":"Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B","volume":"120","author":"Rao","year":"2012","journal-title":"Blood."},{"issue":"24","key":"2021072315342270700_B32","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"Gutierrez","year":"2010","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021072315342270700_B33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","article-title":"The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children","volume":"110","author":"Clappier","year":"2007","journal-title":"Blood."},{"issue":"7137","key":"2021072315342270700_B34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature."},{"issue":"4","key":"2021072315342270700_B35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet."},{"issue":"10","key":"2021072315342270700_B36","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ng1425","article-title":"Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia","volume":"36","author":"Graux","year":"2004","journal-title":"Nat Genet."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2890\/1815127\/advancesadv2021004334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2890\/1815127\/advancesadv2021004334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:34:50Z","timestamp":1627054490000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/14\/2890\/476418\/Genomic-and-clinical-characterization-of-early-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":36,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,7,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004334","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}